Market Currents
Jefferies says Hologic's (HOLX +1.2%) pending acquisition of Gen-Probe (GPRO +0.5%) could be a...
-
Monday, June 18, 2012, 2:49 PM ETJefferies says Hologic's (HOLX +1.2%) pending acquisition of Gen-Probe (GPRO +0.5%) could be a significant earnings driver for the combined company. The firm believes the combination could generate $2.68 in EPS including almost $1.00 in incremental earnings by FY15. Jefferies says HOLX is very attractive at current levels and reiterates a Buy on the name with a $24 price target.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
